Variant angina associated with bitter orange in a dietary supplement
- PMID: 16610576
- DOI: 10.4065/81.4.545
Variant angina associated with bitter orange in a dietary supplement
Abstract
The Food and Drug Administration has banned the sale of ephedrine-based weight-loss products because of their association with many cardiovascular adverse effects. Bitter orange is now being used as a stimulant in "ephedra-free" weight-loss supplements but was recently implicated in adverse cardiovascular sequelae. To our knowledge, this report describes the first case of variant angina associated with bitter orange in a dietary supplement.
Comment in
-
Reporting associations between dietary supplements and adverse events.Mayo Clin Proc. 2006 Dec;81(12):1636; author reply 1636-7. doi: 10.4065/81.12.1636. Mayo Clin Proc. 2006. PMID: 17165644 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical